Search This Blog

Monday, March 2, 2020

Daxor up 86% on coronavirus news

In yet another example of the animal spirits related to any company even mentioning coronavirus, ultra-thinly traded nano cap Daxor (NYSEMKT:DXR) is up 63% premarket, albeit on only 25K shares, in reaction to its announced “engagement” with hospitals and government agencies regarding the use of its blood volume analyzer, BVA-100, in critically ill COVID-19 patients.
It says a clinical trial showed that the use of the device reduced mortality by as much as 66% in patients suffering from respiratory distress and septic shock, adding that it has an inventory of product “ready for deployment.”
https://seekingalpha.com/news/3547412-daxor-up-86-on-coronavirus-news

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.